Dr. Sabina Paglialunga of Celerion addresses the merits and limitations of non-invasive NAFLD/NASH diagnosis and treatment monitoring modalities such as ultrasound, magnetic resonance and elastography. Panels of soluble biomarkers that can distinguish between advanced fibrosis, NASH and fatty liver are also discussed.
Watch NowIn this webinar, Dr. Evelyn Zöhrer from the Medical University of Graz provides an overview of bile acids with a specific focus on their role in inflammation. She also discusses current methodologies available for the measurement of bile acids.
Watch NowThis short video outlines the features and benefits of our InhibiScreen Kinase Inhibitor Assay which was specifically designed and developed to evaluate the efficacy of lipid kinase inhibitors during lead discovery, lead optimization, and pre-clinical development.
Dr. Darleen Sandoval from the University of Michigan discusses her work to better understand the role of GLP-1 in the metabolic adaptation to bariatric surgery.
Watch NowNicolas Heureux discussed these reasons and also introduced an effective tool from DIAsource that can directly measure free 25OH Vitamin D.
Watch Now